NEW YORK, Sept. 03, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (NASDAQ: INBS) (“INBS” or the “Company”), a leader in non-invasive drug testing technology, today announced significant ...
Ribbon Bio GmbH, the DNA synthesis company, has been named A Best Place to Work 2025 by GenomeWeb in the mid-size category of 51-100 employees. This recognition reflects Ribbon’s commitment to ...
Keeping valuable employees happy-and on the job-may test bio/pharma business decisions. The bio/pharma industry has found itself under the microscope as executives search for answers to criticisms ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback